Omada Health will present at the J.P. Morgan Healthcare Conference on January 14, showcasing its virtual healthcare solutions.
Quiver AI Summary
Omada Health, a virtual healthcare provider focused on managing cardiometabolic conditions, announced its participation in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 14 at 9 a.m. PST, with a presentation available via webcast. Omada utilizes a unique approach called Compassionate Intelligence, which integrates human care teams, connected devices, and AI technology to offer personalized care. With over a decade of experience serving more than one million members across various healthcare sectors, Omada has been recognized for its evidence-based strategies and has achieved multiple healthcare accreditations. For further details, both the live webcast and a replay will be accessible on their investor relations website.
Potential Positives
- Participation in the prestigious 44th Annual J.P. Morgan Healthcare Conference highlights the company's industry presence and commitment to engaging with key stakeholders.
- The announcement of a detailed webcast allows for broader accessibility and transparency, providing stakeholders with insight into the company's strategies and goals.
- Omada Health's decade-long experience serving over one million members and its extensive collaboration with diverse customers signify its established credibility and market position in virtual healthcare.
- The company’s unique approach, incorporating AI-powered technology and evidence-based practices, positions it as an innovator in managing chronic conditions, enhancing its competitive advantage in the healthcare industry.
Potential Negatives
- None
FAQ
What is the date and time of Omada Health's presentation at the J.P. Morgan Healthcare Conference?
Omada Health's presentation is scheduled for Wednesday, Jan. 14, at 9 a.m. PST.
Where can I watch the Omada Health conference presentation?
The presentation can be viewed online at https://investors.omadahealth.com/news-events/events.
What conditions does Omada Health focus on?
Omada Health addresses cardiometabolic conditions like diabetes, hypertension, prediabetes, obesity, and musculoskeletal issues.
How does Omada Health deliver personalized care?
Omada's approach combines human-led care teams, connected devices, and AI-powered technology to provide personalized care at scale.
How many members has Omada Health served?
Omada Health has served over one million members across more than 2,000 customers since its launch.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$OMDA Insider Trading Activity
$OMDA insiders have traded $OMDA stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $OMDA stock by insiders over the last 6 months:
- SEAN P. DUFFY (Chief Executive Officer) sold 9,266 shares for an estimated $142,378
- STEVEN L. COOK (Chief Financial Officer) sold 4,211 shares for an estimated $64,704
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$OMDA Revenue
$OMDA had revenues of $68M in Q2 2025. This is an increase of 65.07% from the same period in the prior year.
You can track OMDA financials on Quiver Quantitative's OMDA stock page.
$OMDA Hedge Fund Activity
We have seen 59 institutional investors add shares of $OMDA stock to their portfolio, and 38 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CIGNA INVESTMENTS INC /NEW added 3,444,630 shares (+inf%) to their portfolio in Q3 2025, for an estimated $76,160,769
- DIVISADERO STREET CAPITAL MANAGEMENT, LP added 1,379,941 shares (+inf%) to their portfolio in Q3 2025, for an estimated $30,510,495
- FMR LLC removed 689,162 shares (-12.3%) from their portfolio in Q3 2025, for an estimated $15,237,371
- BIT CAPITAL GMBH added 616,873 shares (+inf%) to their portfolio in Q3 2025, for an estimated $13,639,062
- BLACKROCK, INC. added 563,562 shares (+inf%) to their portfolio in Q3 2025, for an estimated $12,460,355
- LOOMIS SAYLES & CO L P added 419,077 shares (+38.4%) to their portfolio in Q3 2025, for an estimated $9,265,792
- VANGUARD GROUP INC added 417,790 shares (+642.8%) to their portfolio in Q3 2025, for an estimated $9,237,336
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$OMDA Analyst Ratings
Wall Street analysts have issued reports on $OMDA in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 11/13/2025
- Needham issued a "Buy" rating on 11/07/2025
- Evercore ISI Group issued a "Outperform" rating on 11/07/2025
- Barclays issued a "Overweight" rating on 11/07/2025
- Canaccord Genuity issued a "Buy" rating on 08/08/2025
- JP Morgan issued a "Overweight" rating on 07/01/2025
- Morgan Stanley issued a "Overweight" rating on 07/01/2025
To track analyst ratings and price targets for $OMDA, check out Quiver Quantitative's $OMDA forecast page.
$OMDA Price Targets
Multiple analysts have issued price targets for $OMDA recently. We have seen 10 analysts offer price targets for $OMDA in the last 6 months, with a median target of $27.5.
Here are some recent targets:
- Sean Dodge from BMO Capital set a target price of $27.0 on 11/13/2025
- Ryan MacDonald from Needham set a target price of $28.0 on 11/07/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $28.0 on 11/07/2025
- Saket Kalia from Barclays set a target price of $29.0 on 11/07/2025
- Vikram Kesavabhotla from Baird set a target price of $24.0 on 09/05/2025
- Richard Close from Canaccord Genuity set a target price of $28.0 on 08/08/2025
- Destiny Jackson from JP Morgan set a target price of $20.0 on 07/01/2025
Full Release
SAN FRANCISCO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 44th Annual J.P. Morgan Healthcare Conference, taking place in San Francisco, including a presentation on Wednesday, Jan. 14, at 9 a.m. PST. The webcast will be available online at https://investors.omadahealth.com/news-events/events . A replay will also be available at the same link following the event.
About Omada Health
Omada Health (Nasdaq: OMDA) is a virtual between-visit healthcare provider that addresses cardiometabolic conditions like diabetes, hypertension, prediabetes, and obesity, as well as musculoskeletal issues. Through specialized care tracks, Omada also supports members taking GLP-1s and other anti-obesity medications. Our unique approach of Compassionate Intelligence combines human-led care teams, connected devices, and AI-powered technology to deliver personalized care at scale.
With more than a decade of experience and data, and 30 peer-reviewed publications that showcase its clinical and economic results, Omada has served over one million members since launch across more than 2,000 customers, including pharmacy benefit managers, health plans, health systems, and employers ranging in size from small businesses to Fortune 500s. Its evidence-based approach and commitment to bending the curve of chronic disease has earned the company multiple healthcare accreditations and recognition in the industry.
As a trusted partner in the healthcare ecosystem, Omada delivers measurable results that help to improve health outcomes and to manage healthcare costs. For more information, visit omadahealth.com.
Contacts
Allan Kells
[email protected]
Rose Ramseth
[email protected]
